Question 1

What is the catalog number for Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody?

Accepted Answer

The catalog number for Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody is orb1619018.

Question 2

What sizes are available for Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody?

Accepted Answer

Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody is available in the following size(s): 100 µL.

Question 3

Is Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody in stock?

Accepted Answer

Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody used for?

Accepted Answer

Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody

Question 5

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

Question 6

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 7

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Cleaved-Caspase-8 (D384) Polyclonal Conjugated Antibody

Product Specifications

UniProt

Reactivity

Clonality

Conjugation

Source

Field of Research

Dilution

Storage Conditions

Notes

Host or Source

Frequently Asked Questions

Explore Other Products

HYAL1 (C-term) Rabbit Polyclonal Antibody

APC Anti-Human CD57 Antibody[HI57a]

APC Anti-Human CD57 Antibody[HI57a]

APC Anti-Human CD57 Antibody[HI57a]

Human ZDHHC4 activation kit by CRISPRa

Chk2 (CHEK2) Human Gene Knockout Kit (CRISPR)